Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

C4 Pathway and CAM01:27

C4 Pathway and CAM

46.0K
Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
46.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

iAstrocytes model cytokine influences on complement expression and neuronal network synchronization.

bioRxiv : the preprint server for biology·2026
Same author

A RiboCancer cell line panel reveals that CLL-associated Rps15 mutations translationally rewire transcription through codon-specific tRNA accommodation defects.

HemaSphere·2026
Same author

Targeting MAPK-dependent pathways to modulate reactive astrocyte pathology in neurodegeneration.

Communications biology·2026
Same author

Protein-guided RNA barcoding links transcriptomes to synaptic architecture.

bioRxiv : the preprint server for biology·2026
Same author

Engulfment by brain macrophages in a short-lived vertebrate.

bioRxiv : the preprint server for biology·2026
Same author

The Genotoxic Stress Sensor ZBP1 Drives Tau Pathology.

Cells·2026

Related Experiment Video

Updated: Aug 16, 2025

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

8.4K

Small-molecule screen reveals pathways that regulate C4 secretion in stem cell-derived astrocytes.

Francesca Rapino1, Ted Natoli2, Francesco Limone3

  • 1Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA; Harvard Stem Cell Institute, Harvard University, Cambridge, MA 02138, USA; Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA.

Stem Cell Reports
|December 23, 2022
PubMed
Summary

Researchers identified pathways regulating complement component 4 (C4) production in astrocytes, crucial for brain immune responses and linked to schizophrenia risk. This discovery aids developing new therapies for central nervous system (CNS) diseases.

Keywords:
C4CMapELISA-based screenESCsL1000astrocytescomplement component C4complement systemconnectivity mapdisease modelinghuman embryonic stem cellshuman induced pluripotent stem cellsiPSCsscreenstem cell-derived astrocytes

More Related Videos

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

980
Visualizing and Analyzing Intracellular Transport of Organelles and Other Cargos in Astrocytes
07:19

Visualizing and Analyzing Intracellular Transport of Organelles and Other Cargos in Astrocytes

Published on: August 28, 2019

7.9K

Related Experiment Videos

Last Updated: Aug 16, 2025

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells
10:28

Flow Cytometry-based Drug Screening System for the Identification of Small Molecules That Promote Cellular Differentiation of Glioblastoma Stem Cells

Published on: January 10, 2018

8.4K
Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
09:51

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells

Published on: June 30, 2023

980
Visualizing and Analyzing Intracellular Transport of Organelles and Other Cargos in Astrocytes
07:19

Visualizing and Analyzing Intracellular Transport of Organelles and Other Cargos in Astrocytes

Published on: August 28, 2019

7.9K

Area of Science:

  • Neuroscience
  • Immunology
  • Genetics

Background:

  • The brain's complement system is vital for immune response and synaptic pruning in development and disease.
  • Complement component 4 (C4) is implicated in schizophrenia risk, highlighting the need to understand its regulation.

Purpose of the Study:

  • To identify pathways that modulate the production of complement component 4 (C4) in astrocytes.
  • To develop a disease-relevant assay for screening small molecules affecting C4 secretion.

Main Methods:

  • Developed a 3D protocol for generating large numbers of astrocytes from pluripotent cells.
  • Performed transcriptional profiling to characterize astrocyte populations.
  • Utilized an ELISA-based small-molecule screen to identify modulators of C4 secretion.
  • Constructed a connectivity map to predict and validate regulatory pathways, including c-Jun-kinase.

Main Results:

  • Successfully generated homogeneous populations of dorsal fetal-like astrocytes.
  • Identified epigenetic regulators and intracellular signaling pathway inhibitors that modulate astrocyte C4 secretion.
  • Validated key regulatory pathways, notably one involving c-Jun-kinase.

Conclusions:

  • This study establishes a foundation for understanding and targeting complement cascade pathways in CNS diseases.
  • Findings pave the way for developing novel therapeutic strategies for conditions involving C4 dysregulation, such as schizophrenia.